The global high throughput process development market is expected to reach USD 19.78 billion in 2021

NEW YORK, April 24, 2017 /PRNewswire/ -- Highlights

The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

The global high throughput process development market is expected to reach USD 19.78 billion in 2021 from USD 9.91 billion in 2016, at a CAGR of 14.8% from 2016 to 2021. Growth in the high throughput process development market is mainly driven by the increasing R&D spending, technological advancements in process development, growth in the biopharmaceutical industry, and growing pressure to lower the cost of manufacturing. However, factors such as the high cost of technology and equipment in this market and lack of adequate infrastructural facilities are restraining the growth of this market to a certain extent.


Read the full report: http://www.reportlinker.com/p04825388/High-Throughput-Process-Development-Market-by-Product-Service-Instrument-Software-and-Service-Molecule-Type-Monoclonal-Antibodies-Recombinant-Insulin-Process-Upstream-Downstream-End-User-Forecast-to.html

In recent years, the Asia-Pacific market for high throughput process development has witnessed a significant growth due to the increasing R&D spending, growing trend of outsourcing, growing public-private partnerships, and increasing government funding for infrastructural development are driving the growth of the Asia-Pacific high throughput process development market.

In this report, the global high throughput process development market is segmented on the basis of molecule type, end user, process, product and service, and region. On the basis of molecule type, the market is classified into monoclonal antibodies, vaccine, recombinant insulin, human growth hormones, and others (interferons and interleukins). In 2016, the monoclonal antibodies segment accounted for the largest share of the market due the increasing adoption of targeted immunotherapy and the increasing number of U.S. FDA-cleared therapeutic monoclonal antibodies.

On the basis of end user, the market is segmented into biopharmaceutical manufacturers and contract manufacturing organizations. In 2016, the biopharmaceutical manufacturer accounted for the largest share of the market. The contract manufacturing organizations segment, on the other hand, is expected to be the fastest-growing end-user segment of the market during the forecast period. High R&D investments by biotechnology companies to accelerate drug manufacturing and increasing pressure from regulatory authorities to lower the cost of production are the major factors driving the growth of the biopharmaceutical manufacturers' end-user segment.

New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.

Research Coverage:
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments of the industry.

It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the high throughput process development market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the high throughput process development market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on products offered by the top players in the high throughput process development market
• Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the high throughput process development market
• Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for high throughput process development products across various regions
• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the high throughput process development market
• Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the leading players in the high throughput process development market
Read the full report: http://www.reportlinker.com/p04825388/High-Throughput-Process-Development-Market-by-Product-Service-Instrument-Software-and-Service-Molecule-Type-Monoclonal-Antibodies-Recombinant-Insulin-Process-Upstream-Downstream-End-User-Forecast-to.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-global-high-throughput-process-development-market-is-expected-to-reach-usd-1978-billion-in-2021-300444603.html

SOURCE Reportlinker